Ancillary-care responsibilities in observational research: two cases, two issues

dc.contributor.author	Mutabingwa, Theonest K.
dc.date.accessioned	2020-10-08T07:15:17Z
dc.date.available	2020-10-08T07:15:17Z
dc.date.issued	2007
dc.description.abstract	International collaborative research in developing countries raises difficult ethical issues in the setting of severe diseases and complex costly treatments. Discussion of two matters has characterized the debate on this type of research. First, what standard of care should be provided to participants in intervention studies, particularly those in control groups? 1,2,3,4 Second, what level of benefits should be provided to individuals and communities during a study and after completion, particularly with respect to treatments proven effective through research? 4, 5, 6 Here, we focus on a third issue, investigators' responsibilities for meeting participants' needs for ancillary care.	en_US
dc.identifier.citation	Dickert, N., DeRiemer, K., Duffy, P.E., Garcia-Garcia, L., Mutabingwa, T.K., Sina, B.J., Tindana, P. and Lie, R., 2007. Ancillary-care responsibilities in observational research: two cases, two issues. The Lancet, 369(9564), pp.874-877.	en_US
dc.identifier.other	DOI:https://doi.org/10.1016/S0140-6736(07)60416-4
dc.identifier.uri	http://hdl.handle.net/123456789/620
dc.language.iso	en	en_US
dc.publisher	The Lancet	en_US
dc.subject	Research methodology	en_US
dc.subject	Ethical issues	en_US
dc.subject	Disease	en_US
dc.title	Ancillary-care responsibilities in observational research: two cases, two issues	en_US
dc.type	Article	en_US